Does a High Omega-3 Index Reduce Risk for Bad Covid-19 Outcomes?
Help FARI find out by supporting a new study
The Fatty Acid Research Institute (FARI; a 501(c)(3) non-profit) has a rare opportunity to partner with a major medical center in Los Angeles to conduct an important clinical study on omega-3 and Covid-19.
We have just completed a peer-reviewed pilot study in 100 patients, and we observed a trend in which a higher Omega-3 Index at admission was associated with a 4-fold lower risk for death from Covid-19 (Read more in our press release). Now that this pilot study is published, we need more samples to do this study properly, ensure the results hold in a larger sample size and get the updated result peer-reviewed and published as soon as possible.
There is no time to submit an NIH-style grant to do this study, so we are reaching out to those of you who have a deep interest in documenting the health benefits of EPA and DHA to help.
The budget for this study includes fees 1) for the hospital system to identify and pull the banked blood samples, to spot them on filter paper for Omega-3 Index analysis, and to find and download the clinical data for each patient; 2) for OmegaQuant Analytics to perform the lab assays (at a steeply discounted rate they have agreed to for this important study); and 3) for FARI to analyze the data, write up the paper for publication and disseminate the results widely.
We estimate that the study will cost $100,000 to get the 1000 patients needed for this study. The faster we get the support, the quicker the study will be done.
Thank you for your tax-deductible support of the Omega-3 Index and COVID-19 Study!
Bill Harris, PhD